Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model

Recruiting now · Not applicable

Conditions studied: Cardiovascular (CV) Risk

In brief

Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk. This study aims to evaluate the effectiveness and feasibility of a cardiovascular prevention pathway delivered remotely through a digital application, comparing it with a traditional in-person care pathway.

Key facts

Study ID

NCT07608926

Run by

Maria Cecilia Hospital

People needed

144

Starts

2025-05-28

Expected to finish

2028-06-01

Last updated by the study team

2026-05-27

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age between 40 and 75 years
• hypertension
• hyperglycaemia
• type 2 diabetes not requiring insulin therapy
• dyslipidaemia
• active smoking
• overweight/grade I obesity
• Willingness to participate in follow-up visits over 24 months

You may not qualify if…

• previous myocardial infarction
• stroke
• transient ischemic attack
• coronary artery diseas
• peripheral arterial occlusive disease
• heart failure
• Type 1 or type 2 diabetes mellitus on insulin therapy
• Advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m²)
• Active cancer disease
• Severe obesity
• Inability to use digital tools
• Pregnancy

Where it is running

• Maria Cecilia Hospital — Cotignola, Ravenna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.